| 000 | 01720 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517151351.0 | ||
| 264 | 0 | _c20170719 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a1460-2156 | ||
| 024 | 7 |
_a10.1093/brain/awx074 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHalliday, Mark | |
| 245 | 0 | 0 |
_aRepurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice. _h[electronic resource] |
| 260 |
_bBrain : a journal of neurology _cJun 2017 |
||
| 300 |
_a1768-1783 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBehavior, Animal |
| 650 | 0 | 4 |
_aChalcones _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aFrontotemporal Dementia _xcomplications |
| 650 | 0 | 4 |
_aMemory Disorders _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aPrion Diseases _xcomplications |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTrazodone _xadministration & dosage |
| 650 | 0 | 4 | _aUnfolded Protein Response |
| 650 | 0 | 4 |
_aeIF-2 Kinase _xantagonists & inhibitors |
| 700 | 1 | _aRadford, Helois | |
| 700 | 1 | _aZents, Karlijn A M | |
| 700 | 1 | _aMolloy, Collin | |
| 700 | 1 | _aMoreno, Julie A | |
| 700 | 1 | _aVerity, Nicholas C | |
| 700 | 1 | _aSmith, Ewan | |
| 700 | 1 | _aOrtori, Catharine A | |
| 700 | 1 | _aBarrett, David A | |
| 700 | 1 | _aBushell, Martin | |
| 700 | 1 | _aMallucci, Giovanna R | |
| 773 | 0 |
_tBrain : a journal of neurology _gvol. 140 _gno. 6 _gp. 1768-1783 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/brain/awx074 _zAvailable from publisher's website |
| 999 |
_c27101631 _d27101631 |
||